SOX2 and cancer: Since it has been reported that the overexpression of SOX2 renders A549 cells resistant to cancer drugs, cisplatin and paclitaxel [22,40], we performed drug sensitivity assays of gMock and gSOX2 LUAD cells using the cancer drugs (Figure 6).